Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
New treatment developed for people suffering with Hepatitis C
May 19, 2014
Dr. Curtis Cooper co-authored a paper recently published in the
New England Journal of Medicine
that evaluated a ground-breaking treatment for people who suffer from Hepatitis C, an infectious disease that primarily targets the liver. The study showed that a 12-week treatment using a combination of antiviral medicines provided Hepatitis C cure rates of between 97 and 100 per cent, depending on the strain of the virus. In addition, the therapy did not use interferon, a protein that helps trigger the protective defenses of the immune system. Previous therapies required treatment for at least twice as long – 24 to 48 weeks – and had lower cure rates of 70%.
Read more in the paper
.
About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.
Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)
padmoore@ohri.ca